The Laboratory for Drug Discovery in Neurodegeneration
Greg Ahn
Greg graduated from Cornell University and joined the group in September 2017, as a research scientist. Greg will be working on the synthesis of novel molecules as potential treatments for a number of neurodegenerative diseases. In the future, Greg plans to pursue a career in medicine.
Mike Shultis
Mike is a chemistry graduate from Northeastern University and joined the group in April 2018, as a research scientist. Mike is working on the synthesis of novel molecules for a the EAAT2 project. In the future, Mike plans to pursue a career in medicine.
Lisa Montagnon
Lisa joined the group in September 2017. She is an undergraduate chemistry student from Bath University UK. Lisa is synthesizing new heterocycles for the EAAT2 project for the treatment of AD and ALS.
Dr. Kevin Hodgetts
Director of The Laboratory for Drug Discovery in Neurodegeneration
65 Landsdowne Street
Cambridge, Massachusetts 02139
U.S.A.
Telephone: 617-768-8640
Email: khodgetts@bwh.harvard.edu